BIO has announced re-election of Rachel King, President and CEO, GlycoMimetics, Inc., as Chair of its Board of Directors for the 2014-2015 term. BIO also elected Dan Junius, President and CEO, ImmunoGen, as its new Board Treasurer, and re-elected David Pyott, Chairman, President and CEO, Allergan, Inc., as Board Secretary. In addition, BIO elected 10 new members to its Board of Directors, and the Board elected 19 of its Directors to serve on BIO's Board Executive Committee for new term.
This story is related to the following:Trade Associations